ADAMTS8 and lung cancer: To further verify the impact of ADAMTS8 on the target therapies of EGFR-mutant lung cancer, we assessed the levels of ADAMTS8 in several LUAD cell lines with mutated EGFR based on the sensitivity of TKI treatment.